Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-25T07:30:46.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Point-of-Care Testing for Pandemic Influenza and Biothreats

Published online by Cambridge University Press:  08 April 2013

Richard F. Louie ,
Tyler Kitano ,
T. Keith Brock ,
Robert Derlet  and
Gerald J. Kost
Get access Rights & Permissions [Opens in a new window]

Abstract

New and reemerging infectious diseases, such as pandemic viruses and resistant bacteria, pose a serious threat in the 21st century. Some of these agents represent global security threats. This review provides an overview of diagnostic challenges presented by pandemic influenza and biothreat agents. The article summarizes recent pandemics and disease outbreaks, point-of-care influenza diagnostic tests, biothreat agents, biothreat instrument systems, and technologies in development. It highlights how medical innovation and health care initiatives can help prepare health care professionals and public health personnel to handle future crises. Based on gap analysis for current point-of-care testing deficiencies, it concludes with policy recommendations that will enhance preparedness. (Disaster Med Public Health Preparedness. 2009;3(Suppl 2):S193–S202)

Keywords

diagnostic challengesH1N1outbreaksPOCT (point-of-care testing)rapid diagnosticsswine flu
Type
Review
Information
Disaster Medicine and Public Health Preparedness , Volume 3 , Issue S2 , December 2009 , pp. S193 - S202
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Kobasa, D, Takada, A, Shinya, K, et alEnhanced virulence of influenza A viruses with the haemaglutinin of the 1918 pandemic virus. Nature. 2004;431:703–707.CrossRefGoogle Scholar
2.Hoft, DF, Belshe, RB.The genetic archaeology of influenza. N Engl J Med. 2004;351:2550–2551.CrossRefGoogle ScholarPubMed
3.Tumpey, TM, Basler, CF, Aguilar, PV, et alCharacterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005;310:77–80.Google Scholar
4.Monto, AS.The threat of an avian influenza pandemic. N Engl J Med. 2005;352:323–325.Google Scholar
5.Scholtissek, C, Rohde, W, von Hoyningen, V, et alOn the origin of the human influenza subtypes H2N2 and H3N2. Virology. 1978;87:13–20.CrossRefGoogle ScholarPubMed
6.Kawaoka, Y, Krauss, S, Webster, RG.Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol. 1989;63:4603–4608.Google Scholar
7.World Health Organization. Global Alert and Response: Pandemic (H1N1) 2009–Update 61. http://www.who.int/csr/don/2009_08_12/en/index.html. Accessed August 13, 2009.Google Scholar
8.World Health Organization. Pandemic phase descriptions. http://www.who.int/csr/disease/influenza/GIPA3AideMemoire.pdf. Accessed June 12, 2009.Google Scholar
9.Kman, NE, Nelson, RN.Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. 2008;26:517–547.CrossRefGoogle ScholarPubMed
10.World Health Organization. Crimean-Congo Haemorrhagic Fever in Turkey. http://www.who.int/csr/don/2006_08_08b/en/index.html. Accessed June 8, 2009.Google Scholar
11.World Health Organization. Chikungunya in India. http://www.who.int/csr/don/2006_10_17/en/index.html. Accessed June 8, 2009.Google Scholar
12.Charrel, RN, Lamballerie, X, Raoult, D.Chikungunya outbreaks—the globalization of vectorbourne diseases. N Engl J Med. 2007;8:769–771.Google Scholar
13.Over 22,000 Chikungunya infections. Bangkok Post. May 29, 2009.Google Scholar
14.World Health Organization. End of Ebola Outbreak in the Democratic Republic of the Congo. http://www.who.int/csr/don/2009_02_17/en. Accessed June 8, 2009.Google Scholar
15.World Health Organization. Dengue/Dengue Haemorrhagic Fever in Brazil. http://www.who.int/csr/don/2008_04_10/en/index.html. Accessed June 8, 2009.Google Scholar
16.World Health Organization. Yellow Fever. http://www.who.int/mediacentre/factsheets/fs100/en. Accessed June 8, 2009.Google Scholar
17.World Health Organization. Epidemic and Pandemic Alert and Response: 2002–Tularemia in Kosovo–Update 2. http://www.who.int/csr/don/2002_02_06/en/index.html. Accessed June 8, 2009.Google Scholar
18.Avian influenza: Situtation in Indonesia. http://www.searo.who.int/en/Section10/Section1027/Section2095/Section2366_13425.asp#. Accessed June 8, 2009.Google Scholar
19.World Health Organization. Lassa Fever. http://www.who.int/mediacentre/factsheets/fs179/en/index.html. Accessed June 8, 2009.Google Scholar
20.Briese, T, Janusz, PT, McMullan, LK, et alGenetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009;4:e1000455.Google Scholar
21.World Health Organization. Marburg Haemorrhagic Fever. http://www.who.int/mediacentre/factsheets/fs_marburg/en/index.html. Accessed June 8, 2009.Google Scholar
22.World Health Organization. Meningococcal Meningitis. May 2003. http://www.who.int/mediacentre/factsheets/fs141/en. Accessed June 9, 2009.Google Scholar
23.World Health Organization. Nipah Virus. http://www.who.int/mediacentre/factsheets/fs262/en/index.html. Accessed June 8, 2009.Google Scholar
24.World Health Organization. Outbreaks of Rift Valley fever in Kenya, Somalia and United Republic of Tanzania, December 2006–April 2007. Wkly Epidemiol Rec. 2007;82:169–178.Google Scholar
25.World Health Organization. Epidemic and Pandemic Alert and Response: Summary of Probable SARS Cases With Onset of Illness From 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/index.html. Accessed June 8, 2009.Google Scholar
26.West Nile virus activity–United States, 2007.MMWR Morb Mortal Wkly Rep. 2008;57:720–723.Google Scholar
27.World Health Organization. Plague. http://www.who.int/mediacentre/factsheets/fs267/en/index.html. Accessed June 8, 2009.Google Scholar
28.Thompson, WW, Weintraub, E, Dhankhar, P, et alEstimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Virus. 2009;3:37–49.Google Scholar
29.Thompson, WW, Shay, DK, Weintraub, E, et alMortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186.CrossRefGoogle ScholarPubMed
30.Centers for Disease Control and Prevention. Influenza: The Disease. http://www.cdc.gov/flu/about/disease/index.htm. Accessed June 4, 2009.Google Scholar
31.Derlet RW, Sandrock CE, Nguyen HH, et al. Influenza. Emedicine, April 27, 2009. http://emedicine.medscape.com/article/219557-overview. Accessed May 19, 2009.Google Scholar
32.Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615.Google Scholar
33.Ginocchio, CC, Lotlikar, M, Falk, L, et alClinical performance of the 3M Rapid Detection Flu A+B Test compared to R-mix culture, DFA, and BinaxNow Influenza A+B Test. J Clin Virol. 2009;45:146–149.Google Scholar
34.Ghebremedhin, B, Engelmann, I, Konig, W, et alComparison of the performance of the rapid antigen detection actin Influenza A&B test and RT-PCR in different respiratory specimens. J Med Microbiol. 2009;58:365–370.Google Scholar
35.Grondhal, B, Puppe, W, Weigl, J, et alComparison of the BD Directigin Flu A+B kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and respiratory synctial virus. Clin Microbiol Infect. 2005;11:848–850.Google Scholar
36.Hurt, AC, Alexander, R, Hibbert, J, et alPerformance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39:132–135.Google Scholar
37.Cazacu, AC, Demmler, GJ, Neuman, MA, et alComparison of a new lateral-flow chromatographic membrane immunoassay to viral culture for rapid detection and differentiation of Influenza A and B viruses in respiratory specimens. J Clin Microbiol. 2004;42:3661–3664.CrossRefGoogle Scholar
38.Pabbaraju, K, Tokaryk, KL, Wong, S, et alComparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J Clin Microbiol. 2008;46:3056–3062.CrossRefGoogle ScholarPubMed
39.Kowalski, RP, Karenchak, LM, Romanowski, EG, et alEvaluation of the shell vial technique for detection of ocular adenovirus. Ophthalmology. 1999;106:1324–1327.Google Scholar
40.World Health Organization. WHO Recommendations on the Use of Rapid Testing for Influenza Diagnosis. July 2005. http://www.who.int/csr/disease/avian_influenza/guidelines/RapidTestInfluenza_web.pdf. Accessed June 4, 2009.Google Scholar
41.Gall, A, Hoffmann, B, Harder, T, et alRapid haemagglutinin subtyping and pathotyping of avian influenza viruses by a DNA microarray. J Virol Methods. 2009;160:200–205.Google Scholar
42.Townsend, MB, Dawson, ED, Mehlmann, M, et alExperimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J Clin Microbiol. 2006;44:2863–2871.Google Scholar
43.Huang, Y, Tang, H, Duffy, S, et alMultiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol. 2009;470:390–396.CrossRefGoogle Scholar
44.World Health Organization. Influenza A(H1N1) virus resistant to oseltamivir–2008/2009 influenza season, northern hemisphere. December 30, 2008. http://www.who.int/csr/disease/influenza/H1N120081230.pdf. Accessed June 5, 2009.Google Scholar
45.Gubareva, L, Okomo-Adhiambo, M, Deyde, V, et alUpdate: drug susceptibility of swine-origin influenza A (H1N1) viruses. MMWR Morb Mortal Wkly Rep. 2009;58:433–435.Google Scholar
46.Sharfstein JM. Amendment to RT-PCR Detection Panel: Emergency Use of the Swine Influenza Virus Real-Time RT-PCR Detection Panel. May 2, 2009. http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161563.htm. Accessed June 5, 2009.Google Scholar
47.Centers for Disease Control and Prevention. CDC Protocol of Real-Time RT-PCR for Influenza A (H1N1). http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html. Accessed June 4, 2009.Google Scholar
48.Khan, AS, Sage, MJ.Biological and chemical terrorism: strategic plan for preparedness and response—recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep. 2000;49:1–14.Google Scholar
49.McBride, MT, Masquelier, D, Hindson, BJ, et alAutonomous detection of aerosolized Bacillus anthracis and Yersinia pestis. Anal Chem. 2003;75:5293–5299.CrossRefGoogle ScholarPubMed
50.Hindson, BJ, Makarewicz, AJ, Setlur, US, et alAPDS: the autonomous pathogen detection system. Biosens Bioelectron. 2005;20:1925–1931.Google Scholar
51.Regan, JF, Makarewicz, AJ, Hindson, BJ, et alEnvironmental monitoring for biological threat agents using the autonomous pathogen detection system with multiplexed polymerase chain reaction. Anal Chem. 2008;80:7422–7429.Google Scholar
52.Jernigan, DB, Raghunathan, PL, Bell, BP, et alInvestigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019–1028.Google Scholar
53.Baillie, LWJ.Past, imminent and future human medical countermeasures for anthrax. J Appl Microbiol. 2006;101:594–606.Google Scholar
54.Shepard, CW, Soriano-Gabarro, M, Zell, ER, et alAntimicrobial post exposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis. 2002;8:1124–1132.Google Scholar
55.Kost, GJ.Newdemics, public health, small-world networks, and point-of-care testing. Point of Care. 2006;5:138–144.Google Scholar
56.Jamison, DT, Breman, JG, Measham, AR, et alPriorities in Health. Washington, DC: The World Bank; 2006:216.CrossRefGoogle Scholar
57.Louie, RF, Sumner, SL, Belcher, S, et alThermal stress and point-of-care testing performance: suitability of glucose test strips and blood gas cartridges for disaster response. Disaster Med Public Health Preparedness. 2009;3:13–17.Google Scholar
58.FluView. 2008–2009 Influenza Season Week 22 ending June 6, 2009. http://www.cdc.gov/flu/weekly. Accessed June 12, 2009.Google Scholar
59.Bisoffi, M, Hjelle, B, Brown, DC, et alDetection of viral bioagents using a shear horizontal surface acoustic wave biosensor. Biosens Bioelectron. 2008;23:1397–1403.Google Scholar
60.Zhu, H, Stybayeva, G, Macal, M, et alA microdevice for multiplexed detection of T-cell-secreted cytokines. Lab Chip. 2008;8:2197–2205.Google Scholar
61.Kost, GJ, Korte, B, Beyette, F, et alThe NIBIB Point of Care Technologies Research Network center themes and opportunities for exploratory POC projects. Point of Care. 2008;7:41.CrossRefGoogle Scholar
62.Lam, C, Waldhorn, R, Toner, E, et alThe prospect of using alternative medical care facilities in an influenza pandemic. Biosecur Bioterror. 2006;4:384–390.Google Scholar